Albumin and calcium reference interval using healthy individuals and a data-mining approach.


Journal

Annals of clinical biochemistry
ISSN: 1758-1001
Titre abrégé: Ann Clin Biochem
Pays: England
ID NLM: 0324055

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 11 7 2020
medline: 17 3 2021
entrez: 11 7 2020
Statut: ppublish

Résumé

Harmonization of reference intervals for analytes that have a sound calibration and metrological traceability is a widely recommended practice. The UK Pathology Harmony has recently harmonized reference intervals for calcium and albumin. In this study, we have determined the reference intervals for calcium and albumin on the UK's most commonly used analytical platforms. A prospective reference population of healthy individuals was recruited according to the IFCC CRIDL criteria. A second indirect population was collected from 14 primary care setting and measured in laboratories using various analytical platforms and methods (Roche, Abbott, Beckman and Siemens analytical platforms). In total, 299 subjects were recruited; the central 95th centile values for calcium for three out of four analytical platforms were in a close agreement with UK Pathology Harmony reference intervals of 2.2-2.6 mmol/L. Reference intervals of BCG methods from both cohorts and irrespective of analytical platforms were higher for both lower and upper reference limits than those for BCP. In comparison, the indirect study showed an age-related variation. The younger population reference intervals varied by up to 5.7% at the lower reference limit and up to 12% at the upper reference limit compared with Pathology Harmony reference intervals, and the older population showed a variation of up to 14% at both limits. While calcium reference intervals can be a subject for harmonization, albumin reference intervals studied showed large variation which is unsupportive of embracing a common reference interval for albumin.

Sections du résumé

BACKGROUND
Harmonization of reference intervals for analytes that have a sound calibration and metrological traceability is a widely recommended practice. The UK Pathology Harmony has recently harmonized reference intervals for calcium and albumin. In this study, we have determined the reference intervals for calcium and albumin on the UK's most commonly used analytical platforms.
METHOD
A prospective reference population of healthy individuals was recruited according to the IFCC CRIDL criteria. A second indirect population was collected from 14 primary care setting and measured in laboratories using various analytical platforms and methods (Roche, Abbott, Beckman and Siemens analytical platforms).
RESULTS
In total, 299 subjects were recruited; the central 95th centile values for calcium for three out of four analytical platforms were in a close agreement with UK Pathology Harmony reference intervals of 2.2-2.6 mmol/L. Reference intervals of BCG methods from both cohorts and irrespective of analytical platforms were higher for both lower and upper reference limits than those for BCP. In comparison, the indirect study showed an age-related variation. The younger population reference intervals varied by up to 5.7% at the lower reference limit and up to 12% at the upper reference limit compared with Pathology Harmony reference intervals, and the older population showed a variation of up to 14% at both limits.
CONCLUSION
While calcium reference intervals can be a subject for harmonization, albumin reference intervals studied showed large variation which is unsupportive of embracing a common reference interval for albumin.

Identifiants

pubmed: 32646226
doi: 10.1177/0004563220944204
doi:

Substances chimiques

Serum Albumin 0
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-381

Auteurs

N Jassam (N)

Department of Clinical Biochemistry, Harrogate Foundation Trust, Harrogate, UK.

A Luvai (A)

Department of Clinical Biochemistry, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

D Narayanan (D)

Department of Blood Sciences, Hull Royal Infirmary, Hull, UK.

D Turnock (D)

Department of Clinical Biochemistry, York Teaching Hospital NHS Foundation Trust, York, UK.

G Lee (G)

Department of Clinical Biochemistry, Mater Misericordiae University Hospital, Dublin, Ireland.

K Earp (K)

Department of Clinical Chemistry, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

J West (J)

Department of Clinical Biochemistry and Immunology, Peterborough City Hospital, Peterborough, UK.

A Day (A)

Department of Clinical Biochemistry, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

J Jeffery (J)

Derriford Combined Laboratory, Derriford Hospital, Plymouth, UK.

S Zouwail (S)

Department of Biochemistry & Immunology, University Hospital of Wales, Cardiff, UK.

N El-Farhan (N)

Department of Biochemistry, Aneurin Bevan University Health Board, Newport, UK.

R Dearman (R)

Faculty of Biology, Medicine and Health, Manchester University, Manchester, UK.

K Hayden (K)

Department of Clinical Biochemistry, Manchester University Hospital, Manchester, UK.

S Willett (S)

Department of Clinical Biochemistry, North Cumbria University Hospitals, Carlisle, UK.

J Osborne (J)

Department of Clinical Biochemistry, Manchester University Hospital, Manchester, UK.

J H Barth (JH)

Department of Clinical Biochemistry, Leeds Teaching Hospitals Trust, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH